Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation

NARecruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Depressive Disorder, Major
Interventions
DRUG

L-dopa/Carbidopa

Patients and healthy controls will receive one time administration of L-dopa/Carbidopa (100/25 mg).

DRUG

Placebo

Patients and healthy controls will receive one time administration of Placebo.

Trial Locations (1)

12203

RECRUITING

Klinik für Psychiatrie und Psychotherapie, Steglitz

All Listed Sponsors
collaborator

Prof. Dr. Stefan M. Gold

UNKNOWN

collaborator

Prof. Dr. Soyoung Q Park

UNKNOWN

collaborator

Dr. Ulrike Grittner

UNKNOWN

collaborator

Motognosis GmbH

UNKNOWN

lead

Charite University, Berlin, Germany

OTHER